Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...
Recursion Pharmaceuticals is harnesing the power of artificial intelligence to rapidly develop new drugs. The drugmaker's former lead candidate failed to show evidence of efficacy in a phase 2 study ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Samsungに所属するAI研究者のAlexia Jolicoeur-Martineau氏が小型かつ高性能なAIモデル「Tiny Recursion Model(TRM)」を開発しました。TRMは再帰的推論と呼ばれる手法を採用しており、わずか700万パラメーターという小型モデルでありながらGemini 2.5 Proを超えるベンチマーク ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する